The cell therapy industry has seen aggressive growth in part due to successful CAR-T therapies offering durable cures to patients with primarily liquid tumors. Learnings from CAR-T therapy have led to engineering modifications for the next generation of cell therapy products using a wider range of cell types (TCR, NK, TIL, MIL), allogeneic (“off the shelf”) approaches, and effective treatments for solid tumors. While the vast majority of the current cell therapy indications center around oncology, other therapeutic areas such as autoimmune, cardiology, and neurology continue to advance.
The Catalent Cell & Gene Therapy team is actively engaged in projects across the advanced therapeutics portfolio. Recently, Mesenchymal stem cell therapy is also showing promising impact as a bridge treatment option in alleviating severe symptoms of COVID-19. Catalent is a partner to many COVID-19 treatments across their biologics portfolio and is committed to supporting safe and effective treatments for this global pandemic.
While cell therapies come with promises of a cure, the development and scalability of these treatments come with their own challenges. Our team understands these challenges and is committed to addressing the gaps that exist within both autologous and allogeneic cell therapy process development and manufacturing. We optimize the supply chain to meet the needs of your specific cell and treatment type and streamline your manufacturing process for optimal cell potency. Our best-in-class manufacturing facilities and scientific know-how give our customers an advantage in reducing the complexities of bringing a cell therapy to market faster with commercial readiness. Catalent’s Cell & Gene Therapy teams have nearly a decade of expertise across the entire process from early risk-assessment to viral vector production for gene-enabled cell therapies, along with custom analytical development and manufacturing services. Additionally, our Clinical Supply Services team is prepared to support the future delivery of your product to the clinic.